Keith L. Black, MD
Dr. Keith L. Black, chairman of the neurosurgery department and director of the
Maxine Dunitz Neurosurgical Institute at Cedars.
I could go on and on about Dr. Black, but I
prefer you do your own DD on him, which will be very easy. Google him, or go to your
favorite AI and dig in. Dr. Black has performed over 8,000 brain surgeries. He holds patents
galore, including the drug that helps chemo cross the blood brain barrier, built the entire
Cedars-Sinai neurosurgical department from scratch into a world-class medical center,
and is genuinely one of the nicest human beings you will ever meet. To say this man is
impressive is like saying Elon has a little money. He is the most inspiring person I’ve met,
bar none, in my 57 years on this earth.
Dr. Black has a passion for eradicating Alzheimer’s. His mother died from the disease, and that triggered his mission to find a cure. We believe he has, and they are about to enter phase 1a human clinical trials to prove it. In animal studies the results have been miraculous.
Dr. Black has revolutionized cancer surgery with a patented blacklight laser that allows surgeons to clearly identify cancerous tissues in real-time and remove the tumors and diseased tissues with 99.8% eliciency. This has never been accomplished before. Often times cancer looks just like normal tissue. The surgeon excises the tissue and then you send it pathology for review, which takes days to weeks. Often times surgeons miss some of the cancer and have to go back in. As Dr. Black says, it’s a guessing game. Direct medical/insurance costs for these reoperations total ~$2-3 billion annually nationwide, with breast cancer driving ~25-30%. Human suffering adds $3-10 billion in lost QALYs/productivity, plus unmeasurable emotional toll - equivalent to the "hidden tax" of suboptimal first surgeries. Interventions like the blacklight Laser could save $200-500 million/year by cutting reops 5-10%. For context, total U.S. cancer care will exceed $245 billion by 2030; addressing incomplete resections is a high-ROI target.
This is a gentleman who has been on the cover of Time Magazine and has
been called one of the 50 smartest people on the planet. His CEO of the blacklight laser
company was formerly head of GE’s imaging division and a pioneer of the LASIK procedure.
The drug they are positioning to stop Alzheimer’s was co-developed at City of Hope and
UCLA before they bought the license and eventually the company that discovered it.